[
1. Gilor C, Niessen S, Furrow E, DiBartola S: What’s in a name? Classification of diabetes mellitus in veterinary medicine and why it matters. J Vet Intern Med 2016, 30(4):927-940.10.1111/jvim.14357
]Search in Google Scholar
[
2. Anthony RM, MacLeay JM, Jewell DE, Brejda JJ, Gross KL: Alpha-lipoic acid is an effective nutritive antioxidant for healthy adult dogs. Animals 2021, 11:274.10.3390/ani11020274
]Search in Google Scholar
[
3. Sicree R: The global burden of diabetes. International Diabetes Federation, 2003, 43.
]Search in Google Scholar
[
4. Ilatovskaya DV, Levchenko V, Lowing A, Shuyskiy LS, Palygin O, Staruschenko A: Podocyte injury in diabetic nephropathy: implications of angiotensin II–dependent activation of TRPC channels. Sci Rep 2015, 5(1):1-10.10.1038/srep17637
]Search in Google Scholar
[
5. Nelson RW, Couto CG: Disorders of the endocrinal pancreas. 6th ed. Small Animal Internal Medicine. 2019: Elsevier Health Sciences.
]Search in Google Scholar
[
6. Vora J, Ibrahim H: Clinical manifestations and natural history of diabetic nephropathy, in Comprehensive Clinical Nephrology 2003, Elsevier Limited: Spain. 425-437.
]Search in Google Scholar
[
7. Sangwan P, Khanna K: Consistency of Rat model for diabetic nephropathy. IJAR 2015, 1(9):157-159.
]Search in Google Scholar
[
8. Group G: Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. Lancet 1997, 349(9069):1857-1863.10.1016/S0140-6736(96)11445-8
]Search in Google Scholar
[
9. Luis-Rodríguez D, Martínez-Castelao A, Górriz JL,De-Álvaro F, Navarro-González JF: Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy. World J Diabetes 2012, 3(1):7.10.4239/wjd.v3.i1.7325853622253941
]Search in Google Scholar
[
10. Susztak K, Raff AC, Schiffer M, Böttinger EP: Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 2006, 55(1):225-233.10.2337/diabetes.55.01.06.db05-0894
]Search in Google Scholar
[
11. Riella MC: Diabetes Renal Disease, in Principles of nephrology and water-electrolyte imbalance. 2018, 1558-1667.
]Search in Google Scholar
[
12. Papadopoulou-Marketou N, Paschou SA, Marketos N, Adamidi S, Adamidis S, Kanaka-Gantenbein C: Diabetic nephropathy in type 1 diabetes. Minerva Med 2017, 109(3):218-228.10.23736/S0026-4806.17.05496-929205998
]Search in Google Scholar
[
13. Slaughter TN, Paige A, Spires D, KojimaN, Kyle PB, Garrett MR, Roman RJ, Williams JM: Characterization of the development of renal injury in Type-1 diabetic Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 2013, 305(7):R727-R734.10.1152/ajpregu.00382.2012379880323926133
]Search in Google Scholar
[
14. Kouzi SA, Yang S, Nuzum DS, Dirks-Naylor AJ: Natural supplements for improving insulin sensitivity and glucose uptake in skeletal muscle. Front Biosci (Elite Ed), 2015, 7(1):94-106.10.2741/720
]Search in Google Scholar
[
15. Kamenova P: Improvement of insulin sensitivity in patients with type 2 diabetes mellitus after oral administration of alpha-lipoic acid. Hormones (Athens) 2006, 5(4):251.10.14310/horm.2002.1119117178700
]Search in Google Scholar
[
16. Moini H, Tirosh O, Park YC, Cho KJ, Packer L: R-α-lipoic acid action on cell redox status, the insulin receptor, and glucose uptake in 3T3-L1 adipocytes. Arch Biochem Biophys 2002, 397(2):384-391.10.1006/abbi.2001.268011795898
]Search in Google Scholar
[
17. Corrêa LBNS, da Costa CAS, Ribas JAS, Boaventura GT, Chagas MA: Antioxidant action of alpha lipoic acid on the testis and epididymis of diabetic rats: morphological, sperm and immunohistochemical evaluation. Int Braz J Urol 2019, 45(4):815-824.10.1590/s1677-5538.ibju.2018.0774
]Search in Google Scholar
[
18. Bilska A, Wlodek L: Lipoic acid-the drug of the future. Pharmacol Rep 2005, 57(5):570-577.
]Search in Google Scholar
[
19. Ansar H, Mazloom Z, Kazemi F, Hejazi N: Effect of alpha-lipoic acid on blood glucose, insulin resistance and glutathione peroxidase of type 2 diabetic patients. Saudi Med J 2011, 32(6):584-588.
]Search in Google Scholar
[
20. Berkson BM, Rubin DM, Berkson AJ: Revisiting the ALA/N (α-Lipoic Acid/Low-Dose Naltrexone) protocol for people with metastatic and nonmetastatic pancreatic cancer: a report of 3 new cases. Integr Cancer Ther 2009, 8(4):416-422.10.1177/153473540935208220042414
]Search in Google Scholar
[
21. Hager K, Kenklies M, McAfoose J: Alpha-lipoic acid as a new treatment option for Alzheimer’s disease--a 48 months follow-up analysis. Alter Med Rev 2008, 13(1):74-75.10.1007/978-3-211-73574-9_2417982894
]Search in Google Scholar
[
22. Ramos CSCB, Silva VAPD, Corrêa LBNS, Abboud RS, Boaventura GT, Chagas MA: Long-Term Alpha-Lipoic Acid (ALA) Antioxidant Therapy Reduces Damage in the Cardiovascular System of Streptozotocin-Induced Diabetic Rats. J Diet Suppl 2021, 22:1-15.10.1080/19390211.2021.200429034806528
]Search in Google Scholar
[
23. Koya D, Hayashi K, Kitada M, Kashiwagi A, Kikkawa R, Haneda M: Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. J Am Soc Nephrol 2003, 14(suppl 3):S250-S253.10.1097/01.ASN.0000077412.07578.4412874441
]Search in Google Scholar
[
24. Tankova T, Koev D, Dakovska L: Alpha-lipoic acid in the treatment of autonomic diabetic neuropathy (controlled, randomized, open-label study). Rom J Inter Med 2004, 42(2):457-464.
]Search in Google Scholar
[
25. Mittermayer F, Pleiner J, Francesconi M, Wolzt M: Treatment with α-lipoic acid reduces asymmetric dimethylarginine in patients with type 2 diabetes mellitus. Translational Res 2010, 155(1):6-9.10.1016/j.trsl.2009.08.00420004356
]Search in Google Scholar
[
26. de Souza Abboud R, Chagas MA, de Amorim Ribeiro IC, Corrêa LBNS, Lange RM: A modified protocol of the alloxan technique for the induction of diabetes mellitus in Wistar rats. Med Veterinária (UFRPE) 2020, 14(4):315-318.10.26605/medvet-v14n4-2410
]Search in Google Scholar
[
27. Aguirre-Arias MV, Velarde V, Moreno RD: Effects of ascorbic acid on spermatogenesis and sperm parameters in diabetic rats. Cell Tissue Res 2017, 370(2):305-317.10.1007/s00441-017-2660-628770381
]Search in Google Scholar
[
28. Mohasseb M, Ebied S, Yehia MA, Hussein N: Testicular oxidative damage and role of combined antioxidant supplementation in experimental diabetic rats. J Physiol Biochem 2011, 67(2):185-194.10.1007/s13105-010-0062-221184211
]Search in Google Scholar
[
29. Scherle W: A simple method for volumetry of organs in quantitative stereology. Mikroskopie 1970, 26:57-60.
]Search in Google Scholar
[
30. Bagetti-Filho HJ, Sampaio FJ, Marques RG, Pereira-Sampaio MA: Different from renal artery only clamping, artery and vein clamping causes a significant reduction in number of rat glomeruli during warm ischemia. J Endourol 2012, 26(10):1335-1339.10.1089/end.2012.016622612865
]Search in Google Scholar
[
31. Bancroft J, Layton C: The Hematoxylin and eosin In: Suvarna S. Theory Practice of histological techniques., 7th ed edn Philadelphia: Churchill Livingstone of El Sevier, Philadelphia: Churchill Livingstone of El Sevier, 2013.
]Search in Google Scholar
[
32. de Oliveira Ramos C, Nardeli CR, Campos KKD, Pena KB, Machado DF, Bandeira ACB, de Paula Costa G, Talvani A, Bezerra FS: The exposure to formaldehyde causes renal dysfunction, inflammation and redox imbalance in rats. Exp Toxicol Pathol 2017, 69(6):367-372.10.1016/j.etp.2017.02.00828336174
]Search in Google Scholar
[
33. Chen J, Chen Y, Luo Y, Gui D, Huang J, He D: Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats. Eur J Pharmacol 2014. 736:86-94.10.1016/j.ejphar.2014.04.03724809932
]Search in Google Scholar
[
34. Tunçdemir M, Öztürk M: The effects of angiotensin-II receptor blockers on podocyte damage and glomerular apoptosis in a rat model of experimental streptozotocin-induced diabetic nephropathy. Acta Histochem 2011, 113(8):826-832.10.1016/j.acthis.2010.12.00321269661
]Search in Google Scholar
[
35. Su J, Li SJ, Chen ZH, Zeng CH, Zhou H, Li LS, Liu ZH: Evaluation of podocyte lesion in patients with diabetic nephropathy: Wilms’ tumor-1 protein used as a podocyte marker. Diabetes Res Clin Pract 2010, 87(2):167-175.10.1016/j.diabres.2009.10.02219969384
]Search in Google Scholar
[
36. Iseki K, Ikemiya Y, Kinjo K, Iseki C, Takishita S: Prevalence of high fasting plasma glucose and risk of developing end-stage renal disease in screened subjects in Okinawa, Japan. J Clin Exp Nephrol 2004, 8(3):250-256.10.1007/s10157-004-0293-z15480903
]Search in Google Scholar
[
37. Henegar JR, Bigler SA, Henegar LK, Tyagi SC, Hall JE: Functional and structural changes in the kidney in the early stages of obesity. J Am Societ Nephrol 2001, 12(6):1211-1217.10.1681/ASN.V126121111373344
]Search in Google Scholar
[
38. Singh H, Singh R, Arora R, Mannan R, Buttar HS, Arora S, Singh B: Protective role of Phyllanthus fraternus in alloxan-induced diabetes in rats. J Ayurveda Integr Medicine 2020, 11(4):391-398.10.1016/j.jaim.2019.09.008777249632088092
]Search in Google Scholar
[
39. Winiarska, K, Malinska D, Szymanski K, Dudziak M, Bryla J: Lipoic acid ameliorates oxidative stress and renal injury in alloxan diabetic rabbits. Biochimie 2008, 90(3):450-459.10.1016/j.biochi.2007.11.01018157951
]Search in Google Scholar
[
40. Behrend E, Holford A, Lathan P, Rucinsky R, Schulman R: 2018 AAHA diabetes management guidelines for dogs and cats. J Am Animal Hospit Assoc 2018, 54(1):1-21.10.5326/JAAHA-MS-682229314873
]Search in Google Scholar
[
41. Fracassi F, Ettinger S: Canine diabetes mellitus, in Textbook of Veterinary Internal Medicine. 2017, Elsevier: St. Louis, USA. p. 1767-81.
]Search in Google Scholar
[
42. Davison LJ: Canine diabetes mellitus, in BSAVA Manual of Canine and Feline Endocrinology. 2012, British Small Animal Veterinary Association.10.22233/9781905319893.12
]Search in Google Scholar
[
43. Golbidi S, Alireza Ebadi S, Laher I: Antioxidants in the treatment of diabetes. Curr Diabetes Rev 2011, 7(2):106-125.10.2174/15733991179494072921294707
]Search in Google Scholar
[
44. Seo EY, Ha AW, Kim WK: α-Lipoic acid reduced weight gain and improved the lipid profile in rats fed with high fat diet. Nutr Res Pract 2012, 6(3):195-200.10.4162/nrp.2012.6.3.195339578322808342
]Search in Google Scholar
[
45. Kayhan Kuştepe E, Bahar L, Zayman E, Sucu N, Gül S, Gül M: A light microscopic investigation of the renoprotective effects of α-lipoic acid and α-tocopherol in an experimental diabetic rat model. Biotech Histochem 2020, 95(4):305-316.10.1080/10520295.2019.169594232013590
]Search in Google Scholar
[
46. Feng B, Yan XF, Xue JL, Xu L, Wang H: The protective effects of α-lipoic acid on kidneys in type 2 diabetic Goto-Kakisaki rats via reducing oxidative stress. Int J Mol Sci 2013, 14(4):6746-6756.10.3390/ijms14046746364566323531536
]Search in Google Scholar
[
47. Portari GV, Moraes RCM, Deminice R, Orsatti FL, Merino S: Effects of the supplementation with alpha-lipoic acid on muscular antioxidant biomarkers of trained mice. Med Exp 2017, 4.10.5935/MedicalExpress.2017.01.05
]Search in Google Scholar
[
48. Turkyilmaz IB, Bilgin Sokmen B, Yanardag R: Alpha lipoic acid prevents brain injury in rats administered with valproic acid. J Biochem Molecul Toxicol 2020, 34(11):e22580.10.1002/jbt.2258032662911
]Search in Google Scholar
[
49. Schnackenberg CG, Wilcox CS: The SOD mimetic tempol restores vasodilation in afferent arterioles of experimental diabetes. Kidney Int 2001, 59(5):1859-1864.10.1046/j.1523-1755.2001.0590051859.x11318957
]Search in Google Scholar
[
50. Huang HC, Preisig PA: G1 kinases and transforming growth factor-β; signaling are associated with a growth pattern switch in diabetes-induced renal growth. Kidney Int 2000, 58(1):162-172.10.1046/j.1523-1755.2000.00151.x10886561
]Search in Google Scholar
[
51. Van Buren PN, Toto R: Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management. Adv Chronic Kidney Dis 2011, 18(1):28-41.10.1053/j.ackd.2010.10.003322101421224028
]Search in Google Scholar
[
52. Jheng HF, Hirotsuka M, Goto T, Shibata M, Matsumura Y, Kawada T: Dietary low-fat soy milk powder retards diabetic nephropathy progression via inhibition of renal fibrosis and renal inflammation. Mol Nutr Food Res 2017, 61(3):1600461.10.1002/mnfr.20160046127748993
]Search in Google Scholar
[
53. Gilbert RE, Cooper ME: The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int 1999, 56(5):1627-1637.10.1046/j.1523-1755.1999.00721.x10571771
]Search in Google Scholar
[
54. Cunningham JG, Klein BG: Veterinary physiology. 2007: Saunders Elsevier Philadelphia.
]Search in Google Scholar
[
55. Garovic VD, Wagner SJ, Turner ST, Rosenthal DW, Watson WJ, Brost BC, Rose CH, Gavrilova L, Craigo P, Bailey KR, Achenbach J, Schiffer M, Grande JP: Urinary podocyte excretion as a marker for preeclampsia. Am J Obstet Gynecol 2007, 196(4):320.e1-7.10.1016/j.ajog.2007.02.00717403404
]Search in Google Scholar
[
56. Ojima A, Ishibashi Y, Matsui T, Maeda S, Nishino Y, Takeuchi M, Fukami K, Yamagishi S: Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product–induced protein arginine methyltranferase-1 expression. Am J Pathol 2013, 182(1):132-141.10.1016/j.ajpath.2012.09.01623159951
]Search in Google Scholar
[
57. Siu B, Saha J, Smoyer WE, Sullivan KA, Brosius FC: Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: prevention by lipoic acid treatment. BMC Nephrol 2006, 7(1):1-11.10.1186/1471-2369-7-6143587616539708
]Search in Google Scholar
